Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate
โ Scribed by Lu, Liang-jing ;Bao, Chun-de ;Dai, Min ;Teng, Jia-lin ;Fan, Wei ;Du, Fang ;Yang, Nan-ping ;Zhao, Yin-huan ;Chen, Zhi-wei ;Xu, Jian-hua ;He, Pei-gen ;Wu, Hua-xiang ;Tao, Yi ;Zhang, Miao-jia ;Han, Xing-hai ;Li, Xing-fu ;Gu, Jie-ruo ;Li, Jian-hua ;Yu, Hao
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 97 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory, nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit from treatment with methotrexate (MTX). ## Methods The PRObable rheumatoid arthritis: Methotrex
## Abstract ## Objective Interleukinโ6 (ILโ6) is a pleiotropic cytokine that regulates the immune response, inflammation, and hematopoiesis. Overproduction of ILโ6 plays pathologic roles in rheumatoid arthritis (RA), and the blockade of ILโ6 may be therapeutically effective for the disease. This s